| 000 | 01774nam a2200349 a 4500 | ||
|---|---|---|---|
| 001 | ebr10713652 | ||
| 003 | CaPaEBR | ||
| 006 | m o u | ||
| 007 | cr cn||||||||| | ||
| 008 | 130605s2013 njuad sb 001 0 eng d | ||
| 010 | _z 2013005181 | ||
| 020 | _z9781118312063 | ||
| 020 | _z9781118312056 | ||
| 020 | _z9781118312155 (cloth) | ||
| 020 | _z9781118312131 (e-book) | ||
| 040 |
_aCaPaEBR _cCaPaEBR |
||
| 035 | _a(OCoLC)849914702 | ||
| 050 | 1 | 4 |
_aRJ560 _b.P43 2013eb |
| 245 | 0 | 0 |
_aPediatric drug development _h[electronic resource] : _bconcepts and applications / _ceditors, Andrew E. Mulberg ... [et al.]. |
| 250 | _a2nd ed. | ||
| 260 |
_aHoboken, N.J. : _bWiley, _c2013. |
||
| 300 |
_axiv, 610 p. : _bill. (some col.) |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _apt. I. Past, present, and future of pediatric drug development -- pt. II. Ethical underpinnings -- pt. III. Regulatory guidelines for pediatric drug development -- pt. IV. Preclinical safety assessment -- pt. V. Pharmacological principles in pediatric drug development -- pt. VI. Clinical trial operations -- pt. VII. Clinical trial operations and good clinical trials -- pt. VIII. Clinical efficacy and safety endpoints -- pt. IX. Formulation, chemistry and manufacturing controls. | |
| 533 |
_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2013. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries. |
||
| 650 | 0 | _aPediatric pharmacology. | |
| 650 | 0 | _aDrug development. | |
| 655 | 7 |
_aElectronic books. _2local |
|
| 700 | 1 | _aMulberg, Andrew E. | |
| 710 | 2 | _aebrary, Inc. | |
| 856 | 4 | 0 |
_uhttp://site.ebrary.com/lib/rucke/Doc?id=10713652 _zAn electronic book accessible through the World Wide Web; click to view |
| 999 |
_c629 _d629 |
||